A RubiconMD webinar. We’ll discuss why most modern patients with type 2 diabetes should be considered for GLP-1 therapy, and what to do when GLP-1 agents aren’t accessible.
Health at the crossroads of clinic and community
A RubiconMD webinar. We’ll discuss why most modern patients with type 2 diabetes should be considered for GLP-1 therapy, and what to do when GLP-1 agents aren’t accessible.